To test if XL-SMA missense variants alter the catalytic adenylation activity of Uba1, each missense variant was assayedin vitro against wild-type Uba1 using a novel kinetic assay adapted from Wilsonet al. (Wilson & Aldrich, 2010). This evidence concerns the gene UBA1 and proximal spinal muscular atrophy.